Describe your firm’s approach to litigation and your strategy for building successful teams for trials or other matters. We believe that at the heart of every case is a simple compelling narrative, a narrative that shows the jury why our side should prevail. From the outset of every matter, we work to identify and develop that narrative—in depositions, briefing, and of course at trial. Effectively conveying the narrative is also essential. Both the message and the messenger matter. That is why we are laser-focused on recruiting, training and promoting the best, the brightest and the most diverse trial teams in the practice today.

Discuss the two biggest products liability/mass torts litigation cases your firm worked on in 2019 and how you reached successful outcomes. Wilkinson Walsh won a decisive victory for Bayer in a certified class action trial brought on behalf of One A Day multivitamin consumers. The team’s success began before trial with a motion that reduced potential damages from $4 billion to $600 million. At trial, the team did not call a single defense witness, instead dismantling the plaintiffs’ case through devastating cross- examinations that undermined all claims Bayer had misrepresented the benefits of One A Day multivitamins. The jury returned a full defense verdict after just an hour of deliberations. Wilkinson Walsh is also lead trial counsel for Bayer in litigation concerning Essure, a Food and Drug Administration-approved birth control method made available to women for over a decade. The first trial is anticipated for later this year, and the firm has already helped to secure several important and favorable pretrial rulings for Bayer.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]